You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 4, April 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  Short Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mycosis Fungoides With Blast Cell Transformation

Christine I. Harrington, MB, ChB, MRCP; David N. Slater, B Med Sci, MB, ChB

Arch Dermatol. 1978;114(4):611-612.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

An unusual case of mycosis fungoides underwent apparent blast cell transformation after two years and the patient died in a leukemic state.

Report of a case

A 57-year-old man had a six-month history of raised red patches on the trunk and limbs. The clinical diagnosis of mycosis fungoides was confirmed by a skin biopsy specimen that demonstrated Daurier-Pautrier epidermal abscesses and a dermal "band-like" infiltrate of mixed mononuclear cells, including large and small hyperchromatic mycosis cells.1,2 The initial lesions responded to ultraviolet light and topical fluocinonide and new lesions that appeared after seven months were treated with cyclophosphamide, prednisolone sodium phosphate, and local radiotherapy (total 4,000 R). Eighteen months later, results of the liver function tests became abnormal and inguinal lymphadenopathy developed. Two ten-day courses of chemotherapy (cyclophosphamide, vincristine sulfate, procarbazine hydrochloride, and prednisolone) were administered, but the third course was terminated owing to the development of pancytopenia. During . . . [Full Text PDF of this Article]


Author Affiliations

From the Rupert Hallam Department of Dermatology, Hallamshire Hospital (Dr Harrington) and the Academic Division of Pathology, University of Sheffield Medical School (Dr Slater), Sheffield, England.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.